Search results
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . [2] She has also been a prominent investor in Shark Tank India investing in over 100 companies.
1M Followers, 1,255 Following, 506 Posts - Namita Thapar (@namitathapar) on Instagram: "ED, Emcure. Shark @ Shark Tank India.
Namita Thapar is an Indian entrepreneur. She is the Executive Director of Emcure Pharmaceuticals (as of 2022), an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra.
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
12 hours ago · Namita Thapar’s Emcure Pharmaceuticals shares made a robust debut on July 10, listing at Rs 1,325.05, which is 31.5 percent above the issue price of Rs 1,008.
Namita Thapar is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
6 days ago · Who Is Namita Thapar? Namita Thapar is an accomplished entrepreneur, business leader, and angel investor. She was born on March 21, 1977, and currently serves as Executive Director of Emcure Pharma, a company set up by her father, Satish Ramanlal Mehta.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.
Jul 3, 2024 · Entrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in Emcure Pharmaceuticals. With the company's IPO launch on July 3, Ms Thapar will sell...
